Idalopirdine
id:
idalopirdine-279-9883877
title:
Idalopirdine
text:
Idalopirdine (INN) is a potent and selective 5-HT6 receptor antagonist under development by Lundbeck as an augmentation therapy for the treatment of cognitive deficits associated with Alzheimer's disease and schizophrenia. As of October 2013 it is in phase III clinical trials. A phase III trial of two different daily doses of Lu AE58054 on top of 10 mg of donepezil for mild-to-moderate Alzheimer's failed to meet its primary endpoint with either dose. Two further phase III trials failed too, the
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Idalopirdine
date created:
date modified:
2023-01-17T18:47:20Z
main entity:
{"identifier":"Q855545","url":"https://www.wikidata.org/entity/Q855545"}
image:
fields total:
13
integrity:
14